Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL+ acute lymphoblastic leukemia

Blood (2015) 125 (19): 2968–2973.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals